Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Index levels move with price changes, weighting shifts, and market events. This overview highlights the main drivers behind index fluctuations.
20,883 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Arm Holdings has ridden a scorching AI-fueled rally in 2026, but today’s roughly 10% slide raises questions about mom...
SoFi Technologies is navigating a volatile market as it heads into Q2 results, with analysts signaling potential upsi...
A practical, no-fluss strategy to build reliable cash flow over 10 years using two dividend-driven leaders. Learn why...
Two KKR Co-CEOs bought a combined 175,000 shares in February, signaling confidence as the stock trades in the mid-$90...
Timken stands at a pivotal moment as it reports Q1 2026 earnings. This guide breaks down the business mix, growth dri...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
A 16% dividend raise from American Express has stock watchers talking. This guide breaks down what the move means for...
AI growth stocks may ride the wave of innovation, but a stubborn helium shortage could cap upside. Even if Iran ends,...
A disciplined AI stock approach blends deep research with risk controls. Learn how this fund manager brilliant method...